About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Chicago | 134 Studies

Clinical Trials Kidney DiseaseChicago

Kidney Disease Clinical Trials in Chicago

Find 134 clinical trials for kidney disease near Chicago, Illinois. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 134 trials

CompletedA Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney DiseaseResearchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys' ability to work properly gradually…NCT06522997·Huntsville, Alabama and 152 others

Kidney Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingEASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study.NCT06531824·Huntsville, Alabama and 556 others

Active not recruitingSDCC - Prospective Cohort Study of Chronic Renal InsufficiencyChronic kidney disease (CKD) is a silent epidemic affecting more than 37 million Americans.NCT00304148·Oakland, California and 11 others

CompletedCRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney DiseaseObesity and chronic kidney disease (CKD) are major public health problems.NCT02405650·Chicago, Illinois and 9 others

CompletedA Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney DiseaseThe purpose of this study is to determine if PRT-201 when applied to a limited segment of your blood vessel (about 2 inches) immediately after surgery to create an arteriovenous…NCT01305824·San Diego, California and 22 others

TerminatedAn Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney disease (CKD) who previously…NCT03749447·Birmingham, Alabama and 86 others

CompletedSafety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic HemodialysisThe purpose of the parent study is to assess the short-term safety and tolerability of soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of…NCT01503021·Mobile, Alabama and 30 others

WithdrawnContinuous Renal Replacement Therapy in the Setting of Orthotopic Liver TransplantTo evaluate the efficacy of continuous renal replacement therapy (CRRT) during orthotopic liver transplantation (OLT) in clearing excess solutes and improving acid-base parameters.NCT01619449·Chicago, Illinois

CompletedA Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesThe purpose of this clinical research study is to determine whether dapagliflozin can improve (decrease) blood glucose values in patients with Type 2 diabetes and moderate renal…NCT02413398·Huntsville, Alabama and 86 others

WithdrawnInvestigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKDThis open-labeled, multicenter study is designed to evaluate the efficacy, safety and PK/PD of roxadustat in ESA-naïve and ESA-treated pediatric patients with CKD Stages 3, 4, and…NCT04621331·Chicago, Illinois and 3 others

CompletedA Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney DiseaseTo assess the safety and efficacy of up to two REACT injections given 6 months (+4 weeks) apart and delivered into the biopsied kidney using a percutaneous approach in…NCT02836574·Tucson, Arizona and 15 others

Enrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0There is a growing focus on short- and long-term kidney health in neonates, including those with acute kidney injury (AKI).NCT06823115·Birmingham, Alabama and 86 others

CompletedZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationThis study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease…NCT05021835·Birmingham, Alabama and 1070 others

CompletedAttenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion ImagingThe routine administration of 75 mg of intravenous aminophylline in patients with severe chronic kidney disease undergoing a nuclear stress test with regadenoson (Lexiscan®) can…NCT01336140·Chicago, Illinois

CompletedA Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)This research study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase (PRT-201) in patients both receiving or expecting to receive…NCT02414841·Birmingham, Alabama and 40 others

CompletedMultiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)An open-label, Phase II, multi-center study evaluating multiple doses of DM199 in participants with chronic kidney disease.NCT04123613·Mesa, Arizona and 13 others

CompletedEfficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney DiseaseThe purpose of the study is to determine whether tolvaptan is effective and safe for the treatment of late-stage chronic kidney disease due to autosomal dominant polycystic kidney…NCT02160145·Birmingham, Alabama and 229 others

CompletedEfficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisThis study is designed to assess the efficacy and safety of etelcalcetide (AMG 416) compared with placebo in the treatment of SHPT in CKD patients receiving hemodialysis.NCT01788046·Mobile, Alabama and 105 others

CompletedCKD Report Card Pilot TrialThe investigators will study physician-patient communication at the UCMC nephrology fellow clinic and to test an intervention, the CKD Report Card, to improve that communication…NCT04119570·Chicago, Illinois

Active not recruitingA Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care SettingThis is an observational study in people with chronic kidney disease (CKD) and type 2 diabetes (T2D) who will be receiving finerenone.NCT05348733·Huntsville, Alabama and 55 others

PreviousPage 4 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia